BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector.

The company’s developments include a test to diagnose and monitor acute kidney damage.

Key Areas

  • Cell biology
  • Coagulation
  • Collectins and related products
  • Complement
  • Cytokines and hormones
  • Enzymes
  • Marker molecules
  • Microbiology
  • Oncology
  • Sera and antigens

Key Products

  • Antibodies
  • Immunoassays APC-PCI ELISA kit
  • MBL oligomer ELISA kit
  • NGAL ELISA kit

 Link to Bioporto

Back to list